Inflammation as a new target in CV risk reduction

December 2022

Publication: Physicians Academy of Cardiovascular Education

Source / Author: PACE - CME

“Lowering LCL-c is the first, second and third thing we have to do to lower atherosclerotic event rates, but what can we do beyond LDL-c lowering?” asks Prof. Ridker. He talks about targeting inflammation in patients with residual CV risk.

View here

 

Read more

Cover photo for Caristo's Symposium at SCCT Symposium

February 2023

Author: Caristo Sponsored Symposium

The future of comprehensive cardiovascular risk prediction using CCTA | SCCT Edinburgh 2023

Dr. Nik Sabharwal, Prof. Ronak Rajani and Dr. Alain Tavildari discuss the future of cardiovascular risk prediction and inflammation as…

Read more

July 2022

Author: SCCT

SCCT Symposium : Visualising Coronary Inflammation in CCTA: The Next Frontier for Cardiovascular Risk Prediction

Coronary Inflammation and Cardiovascular Disease Prevention View here